LARISSA KAPPEL: Open Payments
NPI 1275016222 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $30 · 2025 $234
Food & beverage: $234
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $58 |
| Lilly USA, LLC | 3 | $54 |
| ABBVIE INC. | 3 | $50 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: Wegovy, MOUNJARO, ACCRUFER, UBRELVY, SPRAVATO, SYNTHROID, QULIPTA, ZORYVE.
Industry payments across TX — which companies pay providers there.
